Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 11/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11675759 | 0.97 | SMPD1 (0.45) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL202464 | 0.81 | TSHR (0.35) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL9750400 | 0.79 | SMPD1 (0.47) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL28544090 | 0.77 | SMPD1 (0.45) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL433467 | 0.76 | SMPD1 (0.43) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL5909138 | 0.76 | SMPD1 (0.43) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| Lithium Ion SCHEMBL11675763 | 0.75 | SMPD1 (0.31) | SMPD1FDPSGGPS1 | |
| SCHEMBL8920115 | 0.75 | SMPD1 (0.44) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL1921756 | 0.74 | SMPD1 (0.42) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| Ammonia Solution, Strong SCHEMBL29187409 | 0.74 | SMPD1 (0.42) | SMPD1LPAR3LPAR1LPAR2FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023049691-A1 | CDK7 INHIBITORS AND METHODS OF TREATING CANCER | ZENO MANAGEMENT, INC. (US) | 2023-03-30 | — | — | WO | disclosed |
| CN-111465678-B | Grease composition | DDP特种电子材料美国第9有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-112912479-A | Grease composition based on silicone base stock | DDP特种电子材料美国第9有限公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-111465678-A | Grease composition | DDP特种电子材料美国第9有限公司 | 2020-07-28 | — | — | CN | disclosed |
| EP-3628043-A1 | ANALGESIC COMPOUNDS | Recurium IP Holdings, LLC (US) | 2020-04-01 | — | — | EP | disclosed |
| WO-2018213140-A1 | ANALGESIC COMPOUNDS | Zeno Royalties & Milestones, LLC (US) | 2018-11-22 | — | — | WO | disclosed |
| EP-3019195-A2 | COMPOSITION AND RELATIVE KIT FOR PERIODONTAL, IMPLANTOLOGY, AND ENDODONTIC TREATMENT HAVING AN OPTIMISED ANTISEPTIC AND REGENERATING ACTION | Caccianiga, Gianluigi (IT) | 2016-05-18 | — | — | EP | disclosed |
| EP-2242514-B1 | INTRALYMPHATIC CHEMOTHERAPY DRUG CARRIERS | UNIV KANSAS (US) | 2015-09-30 | — | — | EP | disclosed |
| WO-2015004589-A2 | COMPOSITION AND RELATIVE KIT FOR PERIODONTAL, IMPLANTOLOGY, AND ENDODONTIC TREATMENT HAVING AN OPTIMIZED ANTISEPTIC AND REGENERATING ACTION | RINI, Valerio (IT) | 2015-01-15 | — | — | WO | disclosed |
| CN-101965201-B | Intralymphatic chemotherapy drug carrier | UNIV KANSAS | 2013-10-23 | — | — | CN | disclosed |
| US-20120100218-A1 | Intralymphatic Chemotherapy Drug Carriers | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-04-26 | — | — | US | disclosed |
| US-8088412-B2 | Intralymphatic chemotherapy drug carriers | UNIVERSITY OF KANSAS (US) | 2012-01-03 | — | — | US | disclosed |
| CN-101965201-A | Intralymphatic chemotherapy drug carrier | UNIV KANSAS | 2011-02-02 | — | — | CN | disclosed |
| US-20090191152-A1 | INTRALYMPHATIC CHEMOTHERAPY DRUG CARRIERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-07-30 | — | — | US | disclosed |